pharma news today glp-1 obesity drugs today Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford Race to launch weight-loss pills

These medications are typically administered subcutaneously using prefilled pens or autoinjectors, and patients frequently notice small air bubbles in the medication chamber during preparation

Mechanisms of Salmonella entry into host cells

I felt like I had a nervous breakdown a few weeks ago

The STEP 1 trial for semaglutide 2.4mg demonstrated a mean body weight reduction of approximately 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed reductions of up to 22.5% at the highest dose. These are outcomes that approach the efficacy of bariatric surgery in some patient cohorts